unlicensed CBU for Infusion Reaction

Phase-Based Progress Estimates
Abramson Cancer Center of the University of Pennsylvania Medical Center, Philadelphia, PAInfusion Reactionunlicensed CBU - Biological
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will study the safety of using cord blood stem cells in patients with conditions that affect the blood or immune system.

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: within 48 hours of infusion

six months after transplant
Hour 48
Incidence of infusion-related reactions

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

unlicensed CBU
1 of 1

Experimental Treatment

9999 Total Participants · 1 Treatment Group

Primary Treatment: unlicensed CBU · No Placebo Group · Phase 2

unlicensed CBU
Experimental Group · 1 Intervention: unlicensed CBU · Intervention Types: Biological

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: within 48 hours of infusion

Who is running the clinical trial?

New York Blood CenterLead Sponsor
23 Previous Clinical Trials
16,742 Total Patients Enrolled
Alexandra Jimenez, MDPrincipal InvestigatorNY Blood Center

Eligibility Criteria

Age Any Age · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
People of any age and gender can participate.

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%

Frequently Asked Questions

How many participants can join this research program?

"Correct. Data found on clinicaltrials.gov indicates that this research project is actively recruiting participants, which commenced being posted on February 1st 2012 and was recently modified on April 19th 2022. A total of 9999 patients are being sought from 67 distinct medical facilities." - Anonymous Online Contributor

Unverified Answer

Is this research endeavor currently accessible to participants?

"Current information posted to clinicaltrials.gov shows that this research project is recruiting participants. Its first post was on February 1st 2012 and the details were most recently updated April 19th 2022." - Anonymous Online Contributor

Unverified Answer

What risks could potentially accompany the unauthorized use of CBU?

"Our team at Power has assigned unlicensed CBU a score of 2, as the drug is currently being tested in Phase 2 trials and thus there are some safety data but no efficacy evidence." - Anonymous Online Contributor

Unverified Answer

Are there many venues conducting this research endeavor in North America?

"Participating in this medical trial is possible for those near many different locations, such as the Florida Hospital, Florida Center for Cellular Therapy based in Orlando FL, St. Louis University Hospital located in Saint Louis MO, and Northwestern Memorial Hospital in Chicago IL." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.